A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients with Solid

A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients with Solid

1. Abstract
1.1. Objective: The aim of this study was to evaluate the post-marketing safety, tolerability, immunogenicity and efficacy of Bevacizumab (manufactured by Hetero Biopharma) in a broader population of patients with solid tumors.